UK SBS Seahorse XFe96 Analyser
There is no other instrument on the market or in development that can analyse cellular metabolism at this high level. We were one of the pioneer research groups to adopt this technology and published several papers in high impact journals, which could not have been produced without the Seahorse Technology. The Seahorse XFE is now an essential tool in cancer metabolism studies and mitochondrial toxicity research worldwide. Both these areas are priority research projects within the MRC Toxicology Unit strategic plan.
Buyer
UK SHARED BUSINESS SERVICES LIMITED
Value
£148,907
Published
8 May 2017
Closes
3 May 2017
Procurement details
Source
Contracts Finder
Region
United Kingdom
Procurement method
Limited
Category
Goods
Contract starts
3 May 2017
Contract ends
3 Jun 2022
CPV classifications
38434000
Analysers
Lots
Lot default UK SBS Seahorse XFe96 Analyser
£148,907
There is no other instrument on the market or in development that can analyse cellular metabolism at this high level. We were one of the pioneer research groups to adopt this technology and published several papers in high impact journals, which could not have been produced without the Seahorse Technology. The Seahorse XFE is now an essential tool in cancer...
Documents
Unlock document linkAwarded contract notice on Contracts Finder
8 May 2017
Awarded contract notice on Contracts Finder
Award notice · Web page
Contains public sector information licensed under the Open Government Licence v3.0.